...
首页> 外文期刊>American Journal of Psychiatry and Neuroscience >Effectiveness of osmotic-controlled release oral delivery system methylphenidate in the treatment of stuttering that combined with attention-deficit/hyperactivity disorder: A case report
【24h】

Effectiveness of osmotic-controlled release oral delivery system methylphenidate in the treatment of stuttering that combined with attention-deficit/hyperactivity disorder: A case report

机译:渗透控释口服给药系统哌醋甲酯治疗口吃合并注意力不足/多动障碍的疗效:一例

获取原文
           

摘要

Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder in children that shows comorbidity with several psychopathology included stuttering. The prefrontal cortex is the area of brain that sends and receives projections from virtually all cortical sensory systems, motor systems, and many subcortical structures. It has been shown that psychostimulant medication increases activation of the inferior prefrontal cortex and the basal ganglia. Both functional neuroimaging and neuropsychological studies show that psychostimulant medication improves executive functions. Verbal fluency is also considered as one of the executive functions. In this article, we report osmotic-controlled release oral delivery system (OROS) methylphenidate treatment effectiveness of stuttering that combined with ADHD.
机译:注意缺陷/多动障碍(ADHD)是儿童中最常见的神经发育障碍,表现出合并症和几种口吃的精神病理学症状。前额叶皮层是大脑的区域,从几乎所有皮质的感觉系统,运动系统和许多皮质下的结构发送和接收投影。研究表明,精神刺激药可增加下额前额叶皮层和基底神经节的激活。功能性神经影像学和神经心理学研究均表明,精神刺激药可改善执行功能。口语流利度也被视为执行功能之一。在本文中,我们报告了渗透压控释口服给药系统(OROS)哌醋甲酯与ADHD结合治疗口吃的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号